{"schema_version":"secwatch.filing_event.v1","accession":"0001798749-24-000055","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.669481+00:00","generated_at":"2026-05-30T13:24:34.291302+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Aerovate regains Nasdaq audit committee compliance by appointing Habib J. Dable","bullets":["Company notified Nasdaq of noncompliance on Oct 11 due to only two audit committee members after Dr. Katabi's resignation.","Board appointed director Habib J. Dable to the audit committee effective Oct 17, 2024.","With Dable's appointment, Aerovate regained compliance with Nasdaq Listing Rule 5605(c)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001798749-24-000055","json":"https://secwatch.observer/filing/0001798749-24-000055.json","markdown":"https://secwatch.observer/filing/0001798749-24-000055.md","text":"https://secwatch.observer/filing/0001798749-24-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/0001798749-24-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000055/tmb-20241011x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:24:34.291302+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}